首頁 > 市場調查報告書 > 食物/飲料

食品添加劑

市場調查報告書

商品編碼

1560819

全球親水膠體市場 - 2024 - 2031

Global Hydrocolloids Market - 2024 - 2031

出版日期: 2024年09月23日 | 出版商:

DataM Intelligence | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

全球親水膠體市場在 2023 年達到 113.2 億美元，預計到 2031 年將達到 177.8 億美元，2024-2031 年預測期間複合年成長率為 5.8%。

親水膠體是親水性聚合物分散在水中的膠體系統。這些聚合物可以源自各種來源，包括植物、動物、微生物或合成來源，它們通常含有大量羥基，這增強了它們結合水的能力。不同量的水的存在使得親水膠體根據環境的濃度和條件以不同的狀態存在，例如凝膠或溶液。

水膠體敷料因其能夠創造濕潤的癒合環境、吸收滲出物並保護傷口免受外部污染物的影響而廣泛應用於臨床環境中各種類型的傷口。這些敷料含有親水性聚合物，當與傷口液體接觸時會形成凝膠，具有多種優點。

水膠體敷料產生的凝膠層有助於維持傷口周圍的濕潤環境，這對於最佳癒合至關重要。水分促進細胞遷移、增生和新組織的形成，加速癒合過程。

市場動態：

司機

傷口和外科手術發生率上升

全球親水膠體市場的需求受到多種因素的推動。主要因素之一是傷口和外科手術發生率的上升。急性和慢性傷口數量的增加，特別是在老化人口中，是親水膠體市場的重要驅動力。

手術傷口的複雜程度各不相同，從小切口到留下更大、更複雜傷口的大手術。水膠體敷料對於處理這些傷口特別有效，因為它們能夠維持濕潤的環境，這對於癒合至關重要。外科手術的數量是需要傷口護理的廣大患者群。每次手術都存在併發症的風險，包括感染和延遲癒合，因此有效的傷口管理至關重要。

此外，該行業的主要參與者擁有技術進步和產品發布，這將推動該市場的成長。水膠體敷料的創新包括抗菌劑的整合。這些藥物有助於預防感染，這是傷口護理中常見的併發症。透過減少傷口部位的微生物負荷，抗菌水膠體敷料可以提高癒合率並降低傷口相關感染的發生率。

此外，2023 年 8 月，Scapa Healthcare 成功協助一家全球消費品公司在創紀錄的時間內推出了以水膠體為基礎的醫療設備。該公司旨在推出一種新的醫療級親膚水膠體產品，但缺乏內部開發該產品的監管專業知識和能力。

限制

與貼片相關的過敏反應和皮膚刺激、與傳統敷料相比成本較高以及缺乏臨床知識和培訓等因素預計將阻礙市場的發展。

細分市場分析

全球親水膠體市場根據類型、應用、最終用戶和地區進行細分。

燒傷領域約佔全球親水膠體市場佔有率的 54.2%

燒傷領域預計將在預測期內佔據最大的市場佔有率。水膠體敷料由於能夠創造和維持濕潤的癒合環境，因此在處理燒傷傷口方面特別有效。

水膠體敷料提供的水分在為細胞遷移創造最佳微環境方面發揮著至關重要的作用，這對於傷口癒合至關重要。在潮濕的環境中，成纖維細胞和角質形成細胞等細胞可以更容易地穿過傷口床，促進肉芽組織的形成和上皮細胞的再形成，最終加速整個癒合過程。

此外，產業產品推出的主要參與者將推動該市場的成長。例如，主要參與者之一的康德樂水膠體敷料是一種先進的傷口護理產品，專門用於維持濕潤的癒合環境，這對於有效的傷口管理至關重要。這種敷料特別適用於各種類型的傷口，包括壓瘡、輕微燒傷和手術後傷口。

同樣，3M 推出的 3M Tegaderm 水膠體敷料、Nexcare 水膠體和 3M Nu-Derm 標準水膠體敷料也有助於推動這一市場的成長。

此外，業內其他參與者還推出了 BAND-AID 品牌 HYDRO SEAL 用途水膠體凝膠繃帶，為治療小傷口提供了全面的解決方案，在單一繃帶中提供了六大主要優點。

市場地域佔有率

北美約佔全球親水膠體市場佔有率的43.1%

預計北美地區將在預測期內佔據最大的市場佔有率。糖尿病足潰瘍、壓瘡和腿部靜脈潰瘍等慢性傷口盛行率的上升，大大推動了親水膠體市場的發展，特別是在傷口護理領域。慢性傷口在癒合過程中面臨獨特的挑戰，需要專門的敷料來有效控制水分含量並促進癒合。水膠體敷料對於這些目的特別有效，導致醫療保健領域的需求增加。

此外，北美人口老化日益嚴重，也更容易罹患慢性病和傷口。技術進步、醫療保健支出增加以及有利的報銷政策正在幫助推動這一市場的成長。

例如，領先的醫療產品製造商 3M 宣布推出專為管理慢性傷口而設計的新型先進水膠體敷料系列。這條創新產品線預計將對北美親水膠體市場產生重大影響，體現了 3M 推動傷口護理技術進步的承諾。

此外，在該地區，大量關鍵參與者的存在、先進的醫療保健基礎設施以及親水膠體領域的關鍵參與者製造商推動了該市場的成長。例如，2023 年9 月在拉斯維加斯Regenerex 上，Pharma, Inc. 宣布組成綜合管理團隊，並計劃於2023 年第四季開始生產營運。專有配方快速傷口，從而降低併發症的風險。

臨床評估表明，使用其產品治療的慢性傷口中有 95% 在 90 天內實現完全閉合。所有產品均採用 Regenerex 獨特的 QBx 成分，有助於為傷口癒合創造最佳環境。現代傷口敷料（如水膠體和膠原蛋白產品）旨在吸收傷口滲出物，但它們不僅僅是覆蓋和保護傷口區域。

Hydrocolloids are colloidal systems where hydrophilic polymers are dispersed in water. These polymers can originate from various sources, including vegetable, animal, microbial, or synthetic origins, and they typically contain numerous hydroxyl groups, which enhance their ability to bind water. The presence of water in varying amounts allows hydrocolloids to exist in different states, such as gels or solutions, depending on the concentration and conditions of the environment.

Hydrocolloid dressings are widely used in clinical settings for various types of wounds due to their ability to create a moist healing environment, absorb exudate, and protect the wound from external contaminants. These dressings contain hydrophilic polymers that form a gel when they come into contact with wound fluid, providing several benefits.

The gel layer created by the hydrocolloid dressing helps maintain a moist environment around the wound, which is crucial for optimal healing. Moisture promotes cell migration, proliferation, and the formation of new tissue, accelerating the healing process.

Market Dynamics: Drivers

Rising incidence of wounds & surgical procedures

The demand for the global hydrocolloids market is driven by multiple factors. One of the primary factors is the rising incidence of wounds & surgical procedures. The increasing number of acute and chronic wounds, particularly among aging populations, is a significant driver of the hydrocolloid market.

Surgical wounds can vary in complexity, from minor incisions to extensive procedures that leave larger, more complex wounds. Hydrocolloid dressings are particularly effective for managing these wounds due to their ability to maintain a moist environment, which is crucial for healing. The number of surgical procedures is the vast population of patients requiring wound care. Each surgery entails a risk of complications, including infections and delayed healing, making effective wound management essential.

Moreover, key players in the industry have technological advancements and product launches that would drive this market growth. Innovations in hydrocolloid dressings include the integration of antimicrobial agents. These agents help prevent infections, a common complication in wound care. By reducing the microbial load at the wound site, antimicrobial hydrocolloid dressings can enhance healing rates and decrease the incidence of wound-related infections.

Also, in August 2023, Scapa Healthcare successfully assisted a global consumer company in launching a hydrocolloid-based medical device in record time. The company aimed to introduce a new medical-grade, skin-friendly hydrocolloid product but lacked the regulatory expertise and capabilities to develop it internally.

Restraints

Factors such as allergic reactions & skin irritations associated with the patches, high cost compared to traditional dressings, and lack of clinical knowledge and training are expected to hamper the market.

Market Segment Analysis

The global hydrocolloids market is segmented based on type, application, end-user, and region.

The burns segment accounted for approximately 54.2% of the global hydrocolloids market share

The burns segment is expected to hold the largest market share over the forecast period. Hydrocolloid dressings are particularly effective in managing burn wounds due to their ability to create and maintain a moist healing environment.

The moisture provided by hydrocolloid dressings plays a crucial role in creating an optimal microenvironment for cell migration, which is essential for wound healing. In a moist environment, cells such as fibroblasts and keratinocytes can more easily move across the wound bed, promoting the formation of granulation tissue and re-epithelialization, ultimately accelerating the overall healing process.

Moreover, key players in the industry product launch that would propel this market growth. For instance, one of the major players Cardinal Health Hydrocolloid Dressing is an advanced wound care product specifically designed to maintain a moist healing environment, which is crucial for effective wound management. This dressing is particularly suitable for various types of wounds, including pressure ulcers, minor burns, and post-operative wounds.

Similarly, 3M introduced the 3M Tegaderm hydrocolloid dressing, Nexcare hydrocolloid, and 3M Nu-Derm standard hydrocolloid dressings are helped to drive this market growth.

Also, other players in the industry introduced the BAND-AID Brand HYDRO SEAL Purpose Hydrocolloid Gel Bandages offer a comprehensive solution for treating minor wounds, providing six key benefits in a single bandage.

Market Geographical Share

North America accounted for approximately 43.1% of the global hydrocolloids market share

North America region is expected to hold the largest market share over the forecast period. The rising prevalence of chronic wounds, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, significantly drives the hydrocolloids market, particularly in wound care. Chronic wounds present unique challenges in healing and require specialized dressings that can effectively manage moisture levels and promote healing. Hydrocolloid dressings are particularly effective for these purposes, leading to increased demand in the healthcare sector.

Moreover, North America has a growing aging population, which is more susceptible to chronic conditions and wounds. Technological advancements, rising healthcare expenditure, and favorable reimbursement policies are helping to drive this market growth.

For instance, 3M, a leading manufacturer of medical products, announced the launch of a new line of advanced hydrocolloid dressings designed specifically for managing chronic wounds. This innovative product line is expected to have a significant impact on the hydrocolloids market in North America, reflecting 3M's commitment to driving progress in wound care technology.

In addition, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, and key player manufacturers in the hydrocolloids driving this market growth. For instance, in Las Vegas Regenerex in September 2023, Pharma, Inc. announced the formation of its comprehensive management team and plans to start manufacturing operations in the fourth quarter of 2023. The company specializes in wound care products that utilize proprietary formulas aimed at healing wounds quickly, thereby reducing the risk of complications.

Clinical evaluations have demonstrated that 95% of chronic wounds treated with their products achieved complete closure within 90 days. All products incorporate Regenerex's unique QBx ingredients, which help create an optimal environment for wound healing. Modern wound dressings like hydrocolloids and collagen-based products are designed to absorb wound exudate, but they go beyond just covering and protecting the wound area.

Market Segmentation

By Type

Sterile

Non-Sterile

By Application

Burns

Chronic Wounds

Surgical Wounds

Necrotic Wounds

Others

By End-User

Hospitals

Specialty Clinics

Ambulatory Surgical Centres

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the hydrocolloids market include 3M, Amparo medical Technologies., Scapa, Sarasota Medical Products, Cardinal Health., Convatec, Fralock LLC, Hi Tech Products., AMERX Health Care, and DermaRite Industries, LLC. Among others.

Key Developments

In June 2024, The INKEY List launched its Hydrocolloid Invisible Pimple Patches, marking its entry into the pimple patch market. These patches are designed to help reduce the appearance of breakouts, particularly whiteheads, by utilizing hydrocolloid technology combined with active ingredients like salicylic acid. According to Dr. Joshua Zeichner, hydrocolloids are effective because they protect the outer skin layer, absorb excess fluid, and promote healing.

In April 2021, Scapa Healthcare announced enhancements at its Hydrocolloid Technology Center in Orangeburg, New York, as part of its commitment to meeting the increasing global demand for premium medical-grade hydrocolloid adhesive technologies. This facility specializes in the design, development, and manufacturing of hydrocolloid formulations used in various applications, including advanced wound care, ostomy care, and consumer wellness products.

Why Purchase the Report?

To visualize the global hydrocolloids market segmentation based on type, application, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points on the hydrocolloids market in all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in excel consisting of key products of all the major players.

The global hydrocolloids market report would provide approximately 62 tables, 54 figures, and 183 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Incidence of Wounds & Surgical Procedures
- 4.1.2. Restraints
  - 4.1.2.1. Allergic Reactions & Skin Irritations Associated with the Patches
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Sterile *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Non-Sterile

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Burns*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Chronic Wounds
7.4. Surgical Wounds
7.5. Necrotic Wounds
7.6. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Specialty Clinics
8.4. Ambulatory Surgical Centres
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. 3M *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Amparo medical Technologies.
11.3. Scapa
11.4. Sarasota Medical Products
11.5. Cardinal Health.
11.6. Convatec
11.7. Fralock LLC
11.8. Hi-Tech Products.
11.9. AMERX Health Care
11.10. DermaRite Industries, LLC. (*LIST NOT EXHAUSTIVE)